हिंदी में पढ़ें —JantaScope हिंदी
Finance

Mutual Funds Are Looking Beyond the Usual Winners — Healthcare and Capital Goods Stand Out

Indian mutual funds are maintaining meaningful exposure to healthcare and capital goods as fund managers navigate market volatility and look for opportunities linked to defensive earnings, manufacturing and India's investment cycle. The positioning comes as equity mutual-fund inflows strengthened in August 2026 and SIP contributions reached a fresh record.

Mutual Funds Are Looking Beyond the Usual Winners — Healthcare and Capital Goods Stand Out

By Jeet Nirmal

Source: Janta Scope

Healthcare and Capital Goods Gain Attention in Mutual Fund Portfolios as India’s Investment Cycle Evolves

Introduction

Indian mutual funds are navigating a changing equity-market landscape, with healthcare and capital goods emerging as notable areas of portfolio exposure alongside traditional heavyweight sectors such as financial services.

The positioning comes at a time when domestic investors continue to pour money into mutual funds despite volatility in the broader stock market.

In August 2026, equity mutual-fund inflows rose 18.8% from July to ₹29,329 crore, according to Association of Mutual Funds in India data reported by Reuters. Systematic investment plan contributions increased to a record ₹32,297 crore.

Within this environment, portfolio disclosures from individual funds show healthcare and capital goods occupying significant positions — potentially reflecting fund managers' search for a combination of earnings resilience and exposure to India's longer-term investment and manufacturing story.

Healthcare Builds a Strong Presence in Portfolios

Healthcare has emerged as a significant allocation in a number of mutual-fund portfolios.

Recent August 2026 portfolio data for individual schemes shows healthcare allocations of 11.29%, 16.55% and as high as 18.37% among examples available in current fund data.

That does not establish that the entire mutual-fund industry is uniformly increasing healthcare exposure, but it demonstrates the sector's meaningful presence within selected portfolios.

Healthcare can also offer characteristics that differ from highly cyclical parts of the market. Demand for medicines, healthcare services and related products is not entirely dependent on the economic cycle, although individual healthcare and pharmaceutical companies remain exposed to company-specific, regulatory, pricing and valuation risks.

For fund managers trying to balance growth opportunities with market uncertainty, that distinction can make healthcare an important part of portfolio construction.

Capital Goods Reflect India's Investment Story

Capital goods represent a different investment proposition.

Rather than primarily offering defensive characteristics, the sector is closely connected with industrial expansion, infrastructure development, manufacturing investment, power equipment and broader capital expenditure.

Portfolio data again shows meaningful exposure.

One August 2026 fund factsheet showed 10.37% allocated to capital goods, while another had 9.49%. A separate portfolio had healthcare as its largest sector allocation at 18.37%, with capital goods representing another 5.4%.

Infrastructure-focused strategies can naturally carry considerably larger allocations. For example, DSP India T.I.G.E.R. Fund's sector data showed capital goods at 19.90% at the end of August 2026, compared with 18.89% at the end of March.

The important caveat is that sector allocations vary substantially according to each scheme's mandate and investment strategy.

Why Capital Goods Remain an Important Market Theme

The investment case surrounding capital goods is connected to India's wider industrialisation and infrastructure cycle.

Businesses involved in industrial machinery, electrical equipment, engineering, automation and related areas can benefit when companies and governments increase expenditure on new capacity and infrastructure.

Recent investment commentary has also identified niche capital goods, along with aerospace, electronics, auto ancillaries and contract development and manufacturing, as areas potentially positioned to benefit from India's changing manufacturing landscape. At the same time, valuation discipline remains important because strong expectations can already be reflected in share prices.

That creates an important distinction for investors: a strong long-term economic theme does not automatically mean every company within the sector is attractively valued.

Record SIP Contributions Show Retail Investors Are Staying Invested

The sector positioning is taking place against an unusually strong backdrop for India's mutual-fund industry.

Gross monthly SIP contributions reached a record ₹32,297 crore in August, while total mutual-fund industry assets climbed above ₹87 lakh crore, also reaching a record level.

Equity funds have now recorded net inflows for 66 consecutive months, according to the August data reported by Reuters.

The persistence of those flows is significant because Indian equities have continued to experience periods of volatility.

Rather than abandoning equities altogether, domestic investors appear to be maintaining long-term participation through mutual funds.

Mid- and Small-Cap Funds Attract Strong Money

August's data also reveals where investors themselves are directing fresh money.

Inflows into mid-cap funds rose 13% to ₹6,989 crore, while small-cap fund inflows increased 2.6% to ₹7,973 crore.

Large-cap funds, in contrast, recorded ₹1,147 crore of outflows, marking their second consecutive month of net withdrawals.

That divergence is important when interpreting sector movements.

Investor inflows into a mutual-fund category and a fund manager's underlying sector allocation are two different things. Investors may put money into a diversified mid-cap or flexi-cap fund, for example, while the fund manager ultimately decides how much of that capital is exposed to healthcare, capital goods, financials or other industries.

Healthcare and Capital Goods Offer Different Portfolio Roles

One reason the two sectors are interesting together is that they can serve very different purposes within an equity portfolio.

Healthcare can provide exposure to pharmaceuticals, hospitals, diagnostics and other health-related businesses, while capital goods can offer greater sensitivity to industrial expansion and capital expenditure.

In simplified terms, healthcare may contribute an element of earnings resilience while capital goods can provide exposure to economic and infrastructure expansion.

But neither sector is automatically low risk.

Healthcare companies can face regulatory decisions, pricing pressure, product-development risks and international-market uncertainty. Capital-goods businesses can be affected by project delays, order execution, commodity costs, government spending and changes in the investment cycle.

Valuation is another crucial consideration for both.

What the Shift Means for Retail Mutual-Fund Investors

For retail investors, changes in sector exposure inside diversified mutual funds generally should not be interpreted as instructions to buy the same sectors directly.

Professional fund managers continuously adjust portfolios according to valuations, earnings expectations, risk and individual scheme mandates.

A diversified equity fund may therefore increase exposure to one industry while reducing another without changing its overall investment objective.

The more relevant question for investors is whether their chosen mutual fund remains consistent with its mandate, risk profile and their own investment horizon.

The Bigger Picture

The latest data presents two related developments.

First, Indian households continue to demonstrate substantial participation in mutual funds, illustrated by record SIP contributions and 66 consecutive months of equity-fund net inflows.

Second, individual portfolio disclosures demonstrate that healthcare and capital goods have become meaningful components of several equity strategies, even though the available evidence does not justify claiming that every mutual fund is rotating aggressively toward the two sectors.

That distinction matters.

The story is therefore less about investors abandoning one sector for another and more about how professional portfolios are positioning themselves across India's evolving economic cycle.

If manufacturing, infrastructure and private capital expenditure remain supportive, capital goods could continue to command fund-manager attention. Healthcare, meanwhile, offers a separate earnings and diversification story.

Together, the sectors illustrate how mutual funds are searching for opportunities beyond simply following India's largest benchmark stocks.

Related

More stories

India’s Q2 Economic Indicators Signal Strong Momentum Ahead of Festive Season

India ended the July-September quarter with encouraging signals across manufacturing, industrial production, tax collections, digital payments and parts of the automobile market. The data point to resilient economic activity ahead of the festive season, although inflation, energy costs and uneven rural-facing demand remain important risks.

Finance

India’s Q2 Economic Indicators Signal Strong Momentum Ahead of Festive Season

India-US Trade Deal Not Imminent, USTR Says as Negotiations Enter Final Stretch

India and the United States are continuing negotiations on a bilateral trade agreement, but an immediate breakthrough should not be expected, US Trade Representative Jamieson Greer said. His comments came after discussions with Indian Commerce and Industry Minister Piyush Goyal at the G20 Trade Ministers’ Meeting in Milwaukee. Both sides say negotiations are progressing, although unresolved issues remain.

Finance

India-US Trade Deal Not Imminent, USTR Says as Negotiations Enter Final Stretch

Finance Ministry Sees India’s Q2 FY27 GDP Growth at 7.3%, but Global Risks Cloud Outlook

India’s Finance Ministry expects real GDP to grow around 7.3% in the July–September quarter of FY27, extending the economy’s strong start to the fiscal year. The estimate is notably above the Reserve Bank of India’s 6.4% projection for the quarter, although the ministry has warned that oil prices, trade uncertainty and tighter global financial conditions remain important risks

Finance

Finance Ministry Sees India’s Q2 FY27 GDP Growth at 7.3%, but Global Risks Cloud Outlook

FPI Outflows Cross ₹1 Trillion in H1 FY27 as Global Pressures Weigh on Indian Markets

Foreign portfolio investors remained cautious toward Indian markets during the first half of FY27, with net selling reaching ₹1.29 trillion. Financial services, oil and gas, automobiles and telecom faced significant withdrawals, while selected consumer and services sectors continued to attract overseas capital.

Finance

FPI Outflows Cross ₹1 Trillion in H1 FY27 as Global Pressures Weigh on Indian Markets

RBI FX Swaps Open Cheaper Dollar Funding Route for Some Indian Companies

The Reserve Bank of India’s large-scale dollar-rupee swap operations are reshaping currency-market pricing and creating an unusual funding opportunity for some Indian companies. Higher forward premiums mean eligible corporates may be able to borrow in rupees and convert that liability into dollars through currency swaps at a lower effective cost than borrowing directly overseas.

Finance

RBI FX Swaps Open Cheaper Dollar Funding Route for Some Indian Companies

Finance Ministry Estimates India’s Q2 GDP Growth at 7.3% as Momentum Moderates

India’s Finance Ministry expects the economy to grow by 7.3% in the July–September quarter of FY2026-27, according to its nowcasting model. The estimate points to continued economic expansion after 7.8% real GDP growth in April–June, although the ministry has also highlighted risks from geopolitical tensions, trade uncertainty, rising oil prices and tighter global financial conditions.

Finance

Finance Ministry Estimates India’s Q2 GDP Growth at 7.3% as Momentum Moderates